Castillo-Torres SA, Soto-Rincón CA, Chávez-Luévanos B, Estrada-Bellmann I

Language: English
References: 0
Page: 207
PDF size: 53.40 Kb.

Text Extraction

To the Editor,

It was with great interest that we read Rodríguez-Violante et al’s. article on the last issue of Rev Mex Neuroci, regarding the incidence rates of Parkinson’s disease (PD) in Mexico in the 2014-2017 period; the authors report an increase of 26.7% in the average annual percent change from 2014 to 2017. We believe this to be an extremely valuable contribution, being the first nation- wide study on the subject; notwithstanding the limitations, the authors draw our attention to an ever-growing menace: the burden of PD.
PD is the second most common neurodegenerative disease, only second in frequency to Alzheimer’s disease. In 2017, the Global Burden of Neurological Disease reported that PD was the only one with increasing rates of prevalence, disability and death. Last year, the Global Burden of PD study published in The Lancet Neurology reported that worldwide 6.1 million individuals were living with PD, a dramatic increase from the 2.5 million in 1990; emphasizing PD as the fastest-growing neurodegenerative disorder and the need for further epidemiological and clinical studies.